These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36199999)

  • 1. Intra-cavitary brachytherapy in endometrial carcinoma: experience with cobalt-60 source.
    Rullán JAD; Miguelañez MTM; Fernández RC; Gallego MC; Sánchez MM; Vicente FG; García SS
    J Contemp Brachytherapy; 2022 Jun; 14(3):227-232. PubMed ID: 36199999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric comparison of
    Shukla AK; Jangid PK; Rajpurohit VS; Verma A; Dangayach SK; Gagrani V; Rathore NK
    J Cancer Res Ther; 2019; 15(6):1212-1215. PubMed ID: 31898649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vaginal cylinder position on dose distribution in patients with endometrial carcinoma in treatment of vaginal cuff brachytherapy.
    Ozdemir Y; Dolek Y; Onal C
    J Contemp Brachytherapy; 2017 Jun; 9(3):230-235. PubMed ID: 28725246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors.
    Landrum LM; Nugent EK; Zuna RE; Syzek E; Mannel RS; Moore KN; Walker JL; McMeekin DS
    Gynecol Oncol; 2014 Jan; 132(1):50-4. PubMed ID: 24219982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between 2D and 3D planning of high-dose-rate vaginal cuff brachytherapy in patients with stage I-II endometrial cancer using cobalt-60.
    Hashemi FA; Mansouri S; Aghili M; Esmati E; Babaei M; Saeedian A; Moalej S; Jaberi R
    J Contemp Brachytherapy; 2021 Oct; 13(5):526-532. PubMed ID: 34759977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
    Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
    Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric analysis of rectal filling on rectal doses during vaginal cuff brachytherapy.
    Sabater S; Arenas M; Berenguer R; Machin-Hamalainen S; Andres I; Sevillano MM; Jimenez-Jimenez E; Martos A; Lopez-Honrubia V; Fernandez-Lopez J
    Brachytherapy; 2015; 14(4):458-63. PubMed ID: 25900391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Adjuvant Cylinder Brachytherapy for Endometrioid Endometrial Cancer.
    Alban GM; Buscariollo DL; Cheng T; Pretz J; Krechmer B; Buzurovic I; Singer L; King M; Lee L
    Pract Radiat Oncol; 2020; 10(2):95-103. PubMed ID: 31783169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
    Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY
    Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
    Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
    Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60).
    Tormo Ferrero V; Duque Ugarte R; Berenguer Francés MÁ; Cardenal Maciá R
    Clin Transl Oncol; 2017 Nov; 19(11):1409-1413. PubMed ID: 28516398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.
    Townamchai K; Lee L; Viswanathan AN
    Gynecol Oncol; 2012 Nov; 127(2):351-5. PubMed ID: 22850411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer.
    Jeans EB; Breen WG; Mullikin TC; Looker BA; Mariani A; Keeney GL; Haddock MG; Petersen IA
    Int J Gynecol Cancer; 2021 Jun; 31(6):859-867. PubMed ID: 33563642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric Evaluation of Organs at Risk From SAVE Protocol.
    Kunz JN; Huang YJ; Casper AC; Suneja G; Burt LM; Jhingran A; Joyner MM; Harkenrider MM; Small W; Grant JD; Kidd EA; Boucher K; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):274-280. PubMed ID: 37023988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vaginal gauze packing technique with or without balloon in high-dose-rate brachytherapy of uterine cervical cancer: A crossover randomized controlled trial.
    Dhanapalan R; Pandjatcharam J; Saravanan K; Patil NH
    J Contemp Brachytherapy; 2022 Dec; 14(6):551-559. PubMed ID: 36819474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vaginal brachytherapy on survival in stage I endometrioid endometrial carcinoma.
    AlHilli M; Amarnath S; Elson P; Rybicki L; Dowdy S
    Int J Gynecol Cancer; 2020 Jun; 30(6):789-796. PubMed ID: 32184268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
    Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
    Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.